|Articles|June 1, 2003
More patients can try presbyopia reversal
The FDA will allow an increase in the number of clinical trial patients eligible to be treated for presbyopia with SurgiLight's OptiVision system.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
PRIMAvera study: Central vision improvement with subretinal implant
2
FDA approvals in 2025: What changed and why it matters for ophthalmologists
3
Refractory dry eye care: How systemic conditions change the game
4
The year in optometry: 10 stories that defined eye care in 2025
5